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Summary
This thesis deals with hereditary diseases in the synthesis of heme. Heme presents a
prosthetic group in a number of important proteins, like hemoglobin, cytochromes and the
cytochrome P450 oxidases. In chapter 1 the heme synthesis and its regulation are
described. Intermediary products in the synthesis of heme are 8-aminolevulinic acid,
porphobilinogen, and series of compounds called porphyrinogens and porphyrins. In
chapter 1 diseases will be discussed, which are caused by defects in the synthesis of
heme. These diseases are called porphyrias. Almost all porphyrias are autosomal dominant
diseases caused by a decreased activity of one of the eight enzymes involved in the
synthesis of heme. In some cases, such as for example erythropoietic protoporphyria, this
mostly gives rise to permanent clinical symptoms of light sensitivity, as the lowered
enzyme activity leads to accumulation of protoporphyrin in the body. Protoporphyrin in
combination with violet light causes this light sensitivity. In other cases this disease is
asymptomatic. Then one speaks of a latent porphyria, where the reduced enzyme activity is
still sufficient to bring about an undisturbed synthesis of heme. Under certain circum-
stances latent porphyria can temporally pass into acute porphyria, for example after the use
of certain drugs. In that case, an increased demand for heme arises and the reduced
enzyme activity is no longer sufficient for an undisturbed synthesis of heme. Under these
circumstances accumulation of heme precursors arise. Furthermore, two very rare recessive
forms of porphyria are known, besides one form which can be acquired due to liver
problems. In total, there are seven different forms of porphyria which overall can be
divided, depending on enzyme defects and clinical symptoms, in neurological complaint
and light sensitivity. Neurological porphyrias are acute intermittent porphyria, hereditary
coproporphyria and porphyria variegata. The latter two can also occur as light sensitive
porphyrias. Exclusively light sensitive porphyria are cutanea tarda and erythropoietic
protoporphyria.
Establishment of the diagnosis manifest porphyria can be accomplished by investigation of
porphyrin concentrations in blood, faeces and urine by means of high performance liquid
chromatography (HPLC). In chapter 2.1 we describe a method, developed for this
purpose.
The big problem of porphyrin investigation is the recognition and demonstration of latent
porphyria. Mostly in the latent phase of a porphyria the secretion of porphyrins in urine
and faeces and 8-aminolevulinic acid and porphobilinogen in urine are normal. In addition,
porphyrin determination in faeces is hampered by the fact, that bacteria in the gut
synthesise many porphyrins and convert protoporphyrin into other porphyrins. In chapter
2.2 we go further into this bacterial contribution and its diagnostic consequences.
The determination of porphyrins in bile has the advantagd that the bacterial contribution is
circumvented. In addition the secretion rate of protoporphyrin into bile can be measured.
This is important for patients with erythropoietic protoporphyria, in whom protoporphyrin
accumulates in the liver, giving rise to cholestasis and liver cirrhosis (chapter 2.3). A
second application of porphyrin investigation in bile is the establishment of the diagnosis
of latent forms of variegate porphyria. In the latent form namely, only protoporphyrin is
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increased compared to other porphyrins in bile. In chapter 2.4 the E,nterotest method is
described, whereby in a patient-friendly manner bile can be frequently investigated on
porphyrins. From porphyrin investigations in bile and serum it can further be deduced that
the generally accepted enterohepatic irculation of dicarboxylic porphyrins is not likely to
exist (chapter 2.3 and 2.4).
The chance to inherit a porphyria from both parents is very small. In the first place
dominant forms are already rather rare and so the chance for a homozygous form is very
exceptional. In the second place a certain rest activity of the defective enzyne must be lefl
over because otherwise the homozygous embryo has no viability. Except for acute
intermittent porphyria, for all 6 other porphyria homozygous cases are described. Until
recently a homozygous form of acute intermittent porphyria was considered not to be
viable. In chapter 3 we describe the discovery of the first double heterozygous form of
acute intermittent porphyria. Porphyrin determinations in blood and urine as well as studies
of the DNA composition with respect to porphobilinogen deaminase proved that both
parents of a girl, who died at the age of eight years, had acute intermittent porphyria. The
porphyrin pattern in urine of the girl was very special. Besides very high uroporphyrin
concentrations the urine also contained high concentrations of hydro-uroporphyrin and
porphobilinogen. Coherent with the early presentation of her disease, which normaiiy
becomes manifest at later age, we concluded that she had inherited the porphyria from
both parents.
The mechanism of protoporphyrin excretion into bile, the rate limiting step in removal of
this lipophilic compound from the body, was investigated by means of animal experiments
(chapter 4). It is namely of clinical importance to increase this secretion in subiects with
erythropoietic protoporphyria, so that they run a lesser risk of getting severe liver 1'ailure
by accumulation of protoporphyrin. This investigation revealed that the secretion of
protoporphyrin was linked to the secretion of lipids. This has the possible consequence that
all drugs, which influence the secretion of lipids, also cause changes in the secretion of
protoporphyrin.
In chapter 2.4 and 4 we show that an enterohepatic irculation of dicarboxylic porphyrins
is not likely. However, therapies directed towards the interruption of this enterohepatic
circulation, showed clinical effects, namely a decrease of porphyrin concentrations in blood
and serum. Therefore we have investigated the mechanism on which this phenomenon is
based (chapter 5). After oral intake of cholestyramine resin it became evident that the
solid resin particles quickly appeared in the blood circulation and subsequently were
secreted in urine. During the stay of the resin particles in blood porphyrins present in the
circulation were adsorbed and taken into urine.
For the lipid soluble protoporphyrin we demonstrated that after oral resin intake increased
concentrations were detectable in urine, besides the present of resin particles. The uptake
of solid particles by the gut is called persorption and the phenomenon the Herbst-
Volkheimer effect, the discoverers of this effect.
Conclusions: With the described HPLC method it is very easy to measure a number of
porphyrins in a variety of biological materials. In this way manifest porphyria can be
established and characterized excellently. Further we have demonstrated the presence and
absence of dicarboxylic porphyria in faeces and bile respectively, found a very 
lare case of
porphyr iaandsometatentporptryr ias,andsuppl iedacontr ibut iontotheunravel l ingof the
secretion of protoporphyrin in bile'
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